Literature DB >> 4858112

Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.

S C Barranco, J K Novak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4858112

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  16 in total

Review 1.  [Present state in synchronization therapy of malignant tumors and acute leukemias (author's transl)].

Authors:  H Sauer; W Wilmanns
Journal:  Klin Wochenschr       Date:  1976-03-01

2.  Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patients.

Authors:  Daniel S Oh; Maggie C U Cheang; Cheng Fan; Charles M Perou
Journal:  Radiat Res       Date:  2014-02-14       Impact factor: 2.841

3.  Significance of the Tritiated Thymidine Labeling Index in breast cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

4.  Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.

Authors:  A Di Marco; A M Casazza; C Soranzo; G Pratesi
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 5.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 6.  Kinetic resistance to anticancer agents.

Authors:  M T Dimanche-Boitrel; C Garrido; B Chauffert
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.

Authors:  S H Chambers; N M Bleehen; J V Watson
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

8.  Evidence for induction and repair of potentially lethal damage in plateau-phase V79 cells after exposure to adriamycin. The importance of removal of adriamycin released from the cells during the post-treatment incubation period.

Authors:  G Iliakis
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

9.  The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.

Authors:  S R Smith; A Howell; A Minawa; J M Morrison
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

10.  Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.

Authors:  G J Finlay; W R Wilson; B C Baguley
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.